Intellicell Biosciences Inc (OTC Pink - Limited Information:SVFC)

Data as of 3:52pm ET
 -0.0001 / -8.33%
Today’s Change
Today|||52-Week Range
Technology Services
Information Technology Services

Company Description

Intellicell Biosciences, Inc. operates as a regenerative medicine company focused on the expanding regenerative medical markets using a proprietary, patent pending process to separate adult autologous vascular cells from blood vessels in adult adipose tissue. The company has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. It will also be seeking to develop technology licensing agreements with technology developers, universities, and international business entities. Intellicell Biosciences was founded on June 3, 2011 and is headquartered in New York, NY.

Contact Information

Intellicell Biosciences, Inc.
460 Park Avenue
New York New York 10022
P:(646) 576-8700
Investor Relations:



Individual stakeholders0.21%
Mutual fund holders--
Other institutional--

Top Executives

Steven A. VictorPresident, CEO, Secretary & Treasurer
Leonard L. MazurChief Operating Officer & Director
John HuberChief Financial Officer
Anna RhodesExecutive Vice President-Operations
Vincent S. DuganDirector-National Sales

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.